Disruptor of telomeric silencing 1-like promotes ovarian cancer tumor growth by stimulating pro-tumorigenic metabolic pathways and blocking apoptosisSuresh Chava, Romi Gupta|Oncogenesis|2021Cited by 29
ASAH1 facilitates TNBC by DUSP5 suppression-driven activation of MAP kinase pathway and represents a therapeutic vulnerabilityKiran Kumar Reddi, Romi Gupta|Cell Death and Disease|2024Cited by 6